December 2019
Volume 32, No. 12 |
|
|
|
|
|
|
| COVER STORY |
Feliza Mirasol
The innovative spirit of biotech startups is a driving force behind the development of new therapeutic products, but building a successful biopharmaceutical company from the ground up has its risks and challenges.
read more
| QUALITY/REGULATIONS |
Jill Wechsler
Problems in assuring reliable drug quality and supply dampens progress in bringing lifesaving therapies to market.
read more
|
|
|
BioPharm International December Issue
|
|
| DOWNSTREAM PROCESSING |
Cynthia A. Challener
Ensuring that viral vectors are free of viral contaminants requires a focus on prevention and control.
read more
| MANUFACTURING |
Yanhuai (Richard) Ding, Margaret Marino, Hemant Kumar
Downstream process development and manufacturing play a crucial role to ensure safety, quality, identity, purity, and efficacy.
read more
| UPSTREAM PROCESSING |
Brad Taylor, Dominic Clarke
Accelerated approval pathways and growing demand for cell and gene therapies are putting pressure on providers of cellular starting materials, and they must ensure a steady supply.
read more
|
|
ADVERTISEMENT
Did you miss the invite to our webinars?
Did you know Eurofins BioPharma Product Testing produces several webinars each year? Topics this year included bioprocess residuals, sterility, residual solvents, inhalation testing and cell-based bioassays. If you missed any of them, they are still available on-demand. Click to view the full list now and stay up to date on upcoming webinars.
Register Now
|
|
|
|
|
|
| FROM THE EDITOR |
Rita C. Peters
Nearly four decades after the first diagnosis, the fight to treat HIV/AIDs continues.
read more
| ASK THE EXPERT |
Susan J. Schniepp
Investigating deviations or failures of combination products needs to accommodate both the drug and device components, says Susan J. Schniepp, executive vice-president of post-approval pharma and distinguished
read more
|
|
| EVENTS |
December 9–11, 2019
January 15-16, 2020
February 18–20, 2020
more events
|
|
|
|
|
|